精品国产一区二区桃色

Journal News

Can membrane stress protect mycobacteria?

Anna Hu
By Anna Hu
Nov. 22, 2022

Every now and then, what seems like a minor observation leads to a multiyear journey.

at the University of Massachusetts Amherst studies the pathogenesis of mycobacteria, a genus that includes tuberculosis- and leprosy-causing species. Specifically, they study the multilayered plasma membrane and cell wall system that protect these bacteria — from antiseptic cleaning agents, for instance.

Membrane fluidizers such as benzyl alcohol disrupt mycobacterial membranes (bottom left), leading to inositol acylation of phosphatidylinositol mannosides (top right). Thin-layer chromatography was used to compare the extent of acylation in the presence or absence of benzyl alcohol in nonpathogenic M. smegmatis, pathogenic M. tuberculosis and the related M. abscessusbacterium.
Courtesy of the Morita lab
Membrane fluidizers such as benzyl alcohol disrupt mycobacterial membranes (bottom left), leading to inositol acylation of phosphatidylinositol mannosides (top right). Thin-layer chromatography was used to compare the extent of acylation in the presence or absence of benzyl alcohol in nonpathogenic M. smegmatis, pathogenic M. tuberculosis and the related M. abscessusbacterium.

While working on an unrelated project, lab members noticed that membrane fluidization led two membrane glycolipids (lipids with a carbohydrate attached via glycosidic bond) called phosphatidylinositol mannosides, or PIMs, to undergo acylation. The two triacylated PIMs were transformed into their tetra-acylated forms.

The lab’s study exploring the conditions for and effects of this acylation in the Journal of Lipid Research. Peter Nguyen, an undergraduate researcher in the Morita lab, was first author on the paper. “We wanted to study this phenomenon, this physiological response to a membrane fluidizing, because we thought it might be significant to how mycobacterial cells can respond to certain stresses, like environmental threats,” he said.

Early on, the lab decided to take a systematic approach. Early experiments showed that PIMs are the only major class of bacterial lipids affected by benzyl alcohol, a membrane fluidizer, and that the effect is a biological response (as opposed to an experimental artifact). The scientists also tested other types of membrane stressors, ultimately finding that only membrane fluidizers caused the full acylation effect.

This particular result came about halfway through the experimental process, which was a relief, Nguyen said. “If there was anything (else) being thrown at it that caused acylation, it would have been a much different story.”

One surprising result came when the scientists examined the reaction kinetics of acylation. As with all the experiments, they used high-performance thin-layer chromatography to visualize the presence of each PIM qualitatively and a mannose standard curve to find relative quantities. A time course experiment showed that the conversion of triacylated to tetra-acylated PIMs took just 20 minutes — one of the fastest cases of mass lipid conversions seen to date. Most mass conversions of mature lipids take several hours, so this reaction’s speed indicates an enzymatic mechanism independent of protein synthesis.

The researchers don’t know what this enzyme is, but Nguyen said, “It seems to play a significant role in what’s happening in response to environmental threats.”

They have shown that rapid PIM acylation is conserved among mycobacteria including the tuberculosis pathogen. Now, they need to identify the acyltransferase to understand better how these cells respond to stress, he added. “A lot of the membrane synthesis in mycobacteria is not well (understood), which is a big issue because tuberculosis is still a huge public health threat.”

The researchers also looked at some practical implications of PIM acylation by testing the response of Mycobacterium smegmatis, a nonpathogenic cousin of Mycobacterium tuberculosis, to antiseptic detergents benzethonium chloride and sodium dodecyl sulfate, or BTC and SDS, with and without a membrane fluidizing pretreatment. While the SDS sensitivity was unaffected by benzyl alcohol fluidization, the pretreated cells were far more resistant to BTC than their untreated counterparts.

The team hypothesizes that increased PIM acylation strengthens the membrane and thus the bacteria’s defenses. While it’s not great news for humans trying to avoid life-threatening diseases, the results bring researchers one step closer to understanding how mycobacteria membranes work and, by extension, how we can counter them.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Anna Hu

Anna Hu earned her bachelor's degree in biochemistry from Wellesley College and is now a research assistant at the Harvard School of Public Health. She is a volunteer writer for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Omega-3 fats linked to healthy aging and improved heart metabolism
Journal News

Omega-3 fats linked to healthy aging and improved heart metabolism

Aug. 1, 2025

Scientists from the University of Iowa find that a diet high in polyunsaturated fatty acids from fish oil increases cardiac triglyceride uptake and improves insulin sensitivity. Read more about this recent JLR study.

RA patient blood reveals joint innerworkings
Journal News

RA patient blood reveals joint innerworkings

July 25, 2025

Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
Feature

Using 'nature鈥檚 mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.